News | June 03, 2022
GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
East Syracuse site to serve as the LOTTE Center for North America Operations for LOTTE’s biologics contract development and manufacturing organization (CDMO) business
The company exports mobile surgery equipment to over 100 countries from Pune
Omega plans to further strengthen its capabilities, deepen domain expertise and build new solutions
He will be responsible for ensuring that every dose of medication that ACG Inspection’s pharmaceutical and nutraceutical partners provide is manufactured and delivered exactly as intended
The facility is among 12 centres established worldwide, and the first in Asia
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
This facility will design & develop instruments, perform product reliability performance testing and verification
Subscribe To Our Newsletter & Stay Updated
